» Articles » PMID: 21531565

The Ras-ERK and PI3K-mTOR Pathways: Cross-talk and Compensation

Overview
Specialty Biochemistry
Date 2011 May 3
PMID 21531565
Citations 872
Authors
Affiliations
Soon will be listed here.
Abstract

The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.

Citing Articles

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Lai J, Liu S, Chen Y, Chen J, Li J, Liang Z MedComm (2020). 2025; 6(3):e70126.

PMID: 40066226 PMC: 11892147. DOI: 10.1002/mco2.70126.


Constitutive systemic inflammation in Shwachman-Diamond Syndrome.

Sabbioni G, DAversa E, Breveglieri G, Altieri M, Boni C, Pegoraro A Mol Med. 2025; 31(1):81.

PMID: 40021961 PMC: 11869671. DOI: 10.1186/s10020-025-01133-5.


Different Ras isoforms regulate synaptic plasticity in opposite directions.

Lopez-Merino E, Fernandez-Rodrigo A, Jiang J, Gutierrez-Eisman S, Fernandez de Sevilla D, Fernandez-Medarde A EMBO J. 2025; .

PMID: 39984756 DOI: 10.1038/s44318-025-00390-8.


Exploration of phosphoproteomic association during epimorphic regeneration.

Banu S, Anusha P, Mandal K, Idris M Sci Rep. 2025; 15(1):4854.

PMID: 39924536 PMC: 11808059. DOI: 10.1038/s41598-024-84735-z.


Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment.

Berezovsky A, Nuga O, Datta I, Bergman K, Sabedot T, Gurdziel K PLoS One. 2025; 20(2):e0315171.

PMID: 39919036 PMC: 11805374. DOI: 10.1371/journal.pone.0315171.


References
1.
Flaherty K, Puzanov I, Kim K, Ribas A, McArthur G, Sosman J . Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010; 363(9):809-19. PMC: 3724529. DOI: 10.1056/NEJMoa1002011. View

2.
McKay M, Morrison D . Integrating signals from RTKs to ERK/MAPK. Oncogene. 2007; 26(22):3113-21. DOI: 10.1038/sj.onc.1210394. View

3.
Chung J, Grammer T, Lemon K, Kazlauskas A, Blenis J . PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 1994; 370(6484):71-5. DOI: 10.1038/370071a0. View

4.
Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M . Regulation of Raf-Akt Cross-talk. J Biol Chem. 2002; 277(34):31099-106. DOI: 10.1074/jbc.M111974200. View

5.
Zha J, Harada H, Yang E, Jockel J, Korsmeyer S . Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996; 87(4):619-28. DOI: 10.1016/s0092-8674(00)81382-3. View